international tolerance sponsoring ministry, non-denominational opposing 1007 u.s. based hate groups, inc.

14 saint marks place, #22b
new york, new york 10003

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 14, 2014

NYS DOS ID#
4513328

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2014 - INTERNATIONAL TOLERANCE SPONSORING MINISTRY, NON-DENOMINATIONAL OPPOSING 1007 U.S. BASED HATE GROUPS, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • North Korea Accuses U.S. of ‘Mugging’ Its Diplomats in New York
    By CHOE SANG-HUN - Sunday Jun 18, 2017

    Officials returning from a United Nations conference were about to board a plane when federal agents seized a package they were carrying.

    Source: NYT > Home Page
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • Cyclist Killed by Bus in New York’s First Citi Bike Fatality
    By MATTHEW HAAG and HANNAH ALANI - Tuesday Jun 13, 2017

    Dan Hanegby of Brooklyn fell under a bus’s tires in Chelsea. He worked for Credit Suisse and was once the top-ranked tennis player in Israel.

    Source: NYT > Home Page
  • Amgen’s Heart Data Don’t Impress Drug-Price Evaluation Group
    By Alex Lash - Tuesday Jun 13, 2017

    The drug-price evaluator that the drug companies love to hate has weighed in again, this time casting a skeptical eye on the price of a next-generation heart medicine from Amgen (NASDAQ: AMGN). The group known as ICER, which stands for Institute for Clinical and Economic Review, released a report today that said Amgen’s evolocumab (Repatha) […]

    Source: Xconomy New York
  • Dear iPhone: I Love You. I Hate You.
    Wednesday Jun 21, 2017

    As the Apple Inc. iPhone’s 10th anniversary approaches, Personal Technology columnist Geoffrey A. Fowler penned two letters to tell it how he really feels.

    Source: The Wall Street Journal: U.S. Business
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed